<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32147204</PMID><DateCompleted><Year>2020</Year><Month>11</Month><Day>02</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>17</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0035-3787</ISSN><JournalIssue CitedMedium="Internet"><Volume>176</Volume><Issue>5</Issue><PubDate><Year>2020</Year><Month>May</Month></PubDate></JournalIssue><Title>Revue neurologique</Title><ISOAbbreviation>Rev Neurol (Paris)</ISOAbbreviation></Journal><ArticleTitle>The effects of diet and sex in amyotrophic lateral sclerosis.</ArticleTitle><Pagination><StartPage>301</StartPage><EndPage>315</EndPage><MedlinePgn>301-315</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.neurol.2019.09.008</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0035-3787(20)30397-0</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disease with no known cure. Approximately 90% of ALS cases are sporadic, suggesting there are multiple contributing factors that influence the disease risk, onset, and progression. Diet and sex are two factors that have been reported to alter ALS risk, onset and progression in humans and in animal models, providing potential modifiers of disease. Several epidemiological studies have identified diets that positively affect ALS patients, including various high-calorie fat or sugar-based diets, while animal models have been developed to test how these diets are working on a molecular level. These diets may offset the metabolic alterations that occur in ALS, such as hypermetabolism, lowered body mass index(BMI), and hyperlipidemia. Sex-dependent differences have also come forth from large-scale epidemiological studies as well as mouse-model studies. In addition, sex hormones have been shown to affect disease risk or progression. Herein, studies on the effects of diet and sex on ALS risk, onset, and progression will be reviewed. Understanding these diet- and sex-dependent outcomes may lead to optimized patient-specific therapies for ALS.</AbstractText><CopyrightInformation>Copyright &#xa9; 2020 The Authors. Published by Elsevier Masson SAS.. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pape</LastName><ForeName>J A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Molecular Biology, Provo, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grose</LastName><ForeName>J H</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Molecular Biology, Provo, United States. Electronic address: julianne_grose@byu.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R15 GM100376</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>03</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>France</Country><MedlineTA>Rev Neurol (Paris)</MedlineTA><NlmUniqueID>2984779R</NlmUniqueID><ISSNLinking>0035-3787</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012739">Gonadal Steroid Hormones</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015992" MajorTopicYN="N">Body Mass Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004032" MajorTopicYN="Y">Diet</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012739" MajorTopicYN="N">Gonadal Steroid Hormones</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012727" MajorTopicYN="Y">Sex Characteristics</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic Lateral Sclerosis</Keyword><Keyword MajorTopicYN="N">Diet</Keyword><Keyword MajorTopicYN="N">Metabolism</Keyword><Keyword MajorTopicYN="N">Sex</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>8</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>9</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>3</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>11</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>3</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32147204</ArticleId><ArticleId IdType="mid">NIHMS1572709</ArticleId><ArticleId IdType="pmc">PMC8915943</ArticleId><ArticleId IdType="doi">10.1016/j.neurol.2019.09.008</ArticleId><ArticleId IdType="pii">S0035-3787(20)30397-0</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Association A. Quick Facts About ALS and the ALS Association 2019 [cited
2019 Jan. 10]. Available from: http://www.alsa.org/news/media/quick-facts.html.</Citation></Reference><Reference><Citation>Miller RG, Mitchell JD, Moore DH. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND). Cochrane Database Syst Rev. 2012(3):CD001447. doi: 10.1002/14651858.CD001447.pub3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD001447.pub3</ArticleId><ArticleId IdType="pmc">PMC7055506</ArticleId><ArticleId IdType="pubmed">22419278</ArticleId></ArticleIdList></Reference><Reference><Citation>Ajroud-Driss S, Siddique T. Sporadic and hereditary amyotrophic lateral sclerosis (ALS). Biochim Biophys Acta. 2015;1852(4):679&#x2013;84. Epub 2014/09/07. doi: 10.1016/j.bbadis.2014.08.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2014.08.010</ArticleId><ArticleId IdType="pubmed">25193032</ArticleId></ArticleIdList></Reference><Reference><Citation>Park Y, Park J, Kim Y, Baek H, Kim SH. Association between nutritional status and disease severity using the amyotrophic lateral sclerosis (ALS) functional rating scale in ALS patients. Nutrition. 2015;31(11&#x2013;12):1362&#x2013;7. doi: 10.1016/j.nut.2015.05.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nut.2015.05.025</ArticleId><ArticleId IdType="pubmed">26429656</ArticleId></ArticleIdList></Reference><Reference><Citation>Dupuis L, Oudart H, Rene F, Gonzalez de Aguilar JL, Loeffler JP. Evidence for defective energy homeostasis in amyotrophic lateral sclerosis: benefit of a high-energy diet in a transgenic mouse model. Proceedings of the National Academy of Sciences of the United States of America. 2004;101(30):11159&#x2013;64. Epub 2004/07/21. doi: 10.1073/pnas.0402026101.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0402026101</ArticleId><ArticleId IdType="pmc">PMC503756</ArticleId><ArticleId IdType="pubmed">15263088</ArticleId></ArticleIdList></Reference><Reference><Citation>Steyn FJ, Ioannides ZA, van Eijk RPA, Heggie S, Thorpe KA, Ceslis A, Heshmat S, Henders AK, Wray NR, van den Berg LH, Henderson RD, McCombe PA, Ngo ST. Hypermetabolism in ALS is associated with greater functional decline and shorter survival. J Neurol Neurosurg Psychiatry. 2018;89(10):1016&#x2013;23. Epub 2018/05/01. doi: 10.1136/jnnp-2017-317887.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2017-317887</ArticleId><ArticleId IdType="pmc">PMC6166607</ArticleId><ArticleId IdType="pubmed">29706605</ArticleId></ArticleIdList></Reference><Reference><Citation>Desport JC, Preux PM, Magy L, Boirie Y, Vallat JM, Beaufrere B, Couratier P. Factors correlated with hypermetabolism in patients with amyotrophic lateral sclerosis. Am J Clin Nutr. 2001;74(3):328&#x2013;34. Epub 2001/08/28. doi: 10.1093/ajcn/74.3.328.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ajcn/74.3.328</ArticleId><ArticleId IdType="pubmed">11522556</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouteloup C, Desport JC, Clavelou P, Guy N, Derumeaux-Burel H, Ferrier A, Couratier P. Hypermetabolism in ALS patients: an early and persistent phenomenon. J Neurol. 2009;256(8):1236&#x2013;42. Epub 2009/03/24. doi: 10.1007/s00415-009-5100-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-009-5100-z</ArticleId><ArticleId IdType="pubmed">19306035</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaisman N, Lusaus M, Nefussy B, Niv E, Comaneshter D, Hallack R, Drory VE. Do patients with amyotrophic lateral sclerosis (ALS) have increased energy needs? J Neurol Sci. 2009;279(1&#x2013;2):26&#x2013;9. Epub 2009/02/03. doi: 10.1016/j.jns.2008.12.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2008.12.027</ArticleId><ArticleId IdType="pubmed">19185883</ArticleId></ArticleIdList></Reference><Reference><Citation>Dupuis L, Pradat PF, Ludolph AC, Loeffler JP. Energy metabolism in amyotrophic lateral sclerosis. Lancet Neurol. 2011;10(1):75&#x2013;82. Epub 2010/11/03. doi: 10.1016/S1474-4422(10)70224-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(10)70224-6</ArticleId><ArticleId IdType="pubmed">21035400</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferri A, Coccurello R. What is &#x201c;Hyper&#x201d; in the ALS Hypermetabolism? Mediators Inflamm. 2017;2017:7821672. Epub 2017/10/31. doi: 10.1155/2017/7821672.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2017/7821672</ArticleId><ArticleId IdType="pmc">PMC5610793</ArticleId><ArticleId IdType="pubmed">29081604</ArticleId></ArticleIdList></Reference><Reference><Citation>Dadon-Nachum M, Melamed E, Offen D. The &#x201c;dying-back&#x201d; phenomenon of motor neurons in ALS. J Mol Neurosci. 2011;43(3):470&#x2013;7. Epub 2010/11/09. doi: 10.1007/s12031-010-9467-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12031-010-9467-1</ArticleId><ArticleId IdType="pubmed">21057983</ArticleId></ArticleIdList></Reference><Reference><Citation>Marcuzzo S, Zucca I, Mastropietro A, de Rosbo NK, Cavalcante P, Tartari S, Bonanno S, Preite L, Mantegazza R, Bernasconi P. Hind limb muscle atrophy precedes cerebral neuronal degeneration in G93A-SOD1 mouse model of amyotrophic lateral sclerosis: a longitudinal MRI study. Exp Neurol. 2011;231(1):30&#x2013;7. Epub 2011/05/31. doi: 10.1016/j.expneurol.2011.05.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2011.05.007</ArticleId><ArticleId IdType="pubmed">21620832</ArticleId></ArticleIdList></Reference><Reference><Citation>Vielhaber S, Kunz D, Winkler K, Wiedemann FR, Kirches E, Feistner H, Heinze HJ, Elger CE, Schubert W, Kunz WS. Mitochondrial DNA abnormalities in skeletal muscle of patients with sporadic amyotrophic lateral sclerosis. Brain. 2000;123 (Pt 7):1339&#x2013;48. Epub 2000/06/27.</Citation><ArticleIdList><ArticleId IdType="pubmed">10869047</ArticleId></ArticleIdList></Reference><Reference><Citation>Echaniz-Laguna A, Zoll J, Ponsot E, N&#x2019;Guessan B, Tranchant C, Loeffler JP, Lampert E. Muscular mitochondrial function in amyotrophic lateral sclerosis is progressively altered as the disease develops: a temporal study in man. Exp Neurol. 2006;198(1):25&#x2013;30. Epub 2005/08/30. doi: 10.1016/j.expneurol.2005.07.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2005.07.020</ArticleId><ArticleId IdType="pubmed">16126198</ArticleId></ArticleIdList></Reference><Reference><Citation>Crugnola V, Lamperti C, Lucchini V, Ronchi D, Peverelli L, Prelle A, Sciacco M, Bordoni A, Fassone E, Fortunato F, Corti S, Silani V, Bresolin N, Di Mauro S, Comi GP, Moggio M. Mitochondrial respiratory chain dysfunction in muscle from patients with amyotrophic lateral sclerosis. Arch Neurol. 2010;67(7):849&#x2013;54. Epub 2010/07/14. doi: 10.1001/archneurol.2010.128.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneurol.2010.128</ArticleId><ArticleId IdType="pubmed">20625092</ArticleId></ArticleIdList></Reference><Reference><Citation>Cozzolino M, Carri MT. Mitochondrial dysfunction in ALS. Prog Neurobiol. 2012;97(2):54&#x2013;66. Epub 2011/08/11. doi: 10.1016/j.pneurobio.2011.06.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pneurobio.2011.06.003</ArticleId><ArticleId IdType="pubmed">21827820</ArticleId></ArticleIdList></Reference><Reference><Citation>Krasnianski A, Deschauer M, Neudecker S, Gellerich FN, Muller T, Schoser BG, Krasnianski M, Zierz S. Mitochondrial changes in skeletal muscle in amyotrophic lateral sclerosis and other neurogenic atrophies. Brain. 2005;128(Pt 8):1870&#x2013;6. Epub 2005/05/20. doi: 10.1093/brain/awh540.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awh540</ArticleId><ArticleId IdType="pubmed">15901649</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung MJ, Suh YL. Ultrastructural changes of mitochondria in the skeletal muscle of patients with amyotrophic lateral sclerosis. Ultrastruct Pathol. 2002;26(1):3&#x2013;7. Epub 2002/05/25. doi: 10.1080/01913120252934260.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/01913120252934260</ArticleId><ArticleId IdType="pubmed">12028652</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsitkanou S, Della Gatta PA, Russell AP. Skeletal Muscle Satellite Cells, Mitochondria, and MicroRNAs: Their Involvement in the Pathogenesis of ALS. Front Physiol. 2016;7:403. Epub 2016/09/30. doi: 10.3389/fphys.2016.00403.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2016.00403</ArticleId><ArticleId IdType="pmc">PMC5020084</ArticleId><ArticleId IdType="pubmed">27679581</ArticleId></ArticleIdList></Reference><Reference><Citation>Loeffler JP, Picchiarelli G, Dupuis L, Gonzalez De Aguilar JL. The Role of Skeletal Muscle in Amyotrophic Lateral Sclerosis. Brain Pathol. 2016;26(2):227&#x2013;36. Epub 2016/01/19. doi: 10.1111/bpa.12350.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bpa.12350</ArticleId><ArticleId IdType="pmc">PMC8029271</ArticleId><ArticleId IdType="pubmed">26780251</ArticleId></ArticleIdList></Reference><Reference><Citation>Siklos L, Engelhardt J, Harati Y, Smith RG, Joo F, Appel SH. Ultrastructural evidence for altered calcium in motor nerve terminals in amyotropic lateral sclerosis. Ann Neurol. 1996;39(2):203&#x2013;16. Epub 1996/02/01. doi: 10.1002/ana.410390210.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.410390210</ArticleId><ArticleId IdType="pubmed">8967752</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou J, Yi J, Fu R, Liu E, Siddique T, Rios E, Deng HX. Hyperactive intracellular calcium signaling associated with localized mitochondrial defects in skeletal muscle of an animal model of amyotrophic lateral sclerosis. J Biol Chem. 2010;285(1):705&#x2013;12. Epub 2009/11/06. doi: 10.1074/jbc.M109.041319.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M109.041319</ArticleId><ArticleId IdType="pmc">PMC2804218</ArticleId><ArticleId IdType="pubmed">19889637</ArticleId></ArticleIdList></Reference><Reference><Citation>Capitanio D, Vasso M, Ratti A, Grignaschi G, Volta M, Moriggi M, Daleno C, Bendotti C, Silani V, Gelfi C. Molecular signatures of amyotrophic lateral sclerosis disease progression in hind and forelimb muscles of an SOD1(G93A) mouse model. Antioxid Redox Signal. 2012;17(10):1333&#x2013;50. Epub 2012/05/09. doi: 10.1089/ars.2012.4524.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ars.2012.4524</ArticleId><ArticleId IdType="pmc">PMC3437050</ArticleId><ArticleId IdType="pubmed">22563797</ArticleId></ArticleIdList></Reference><Reference><Citation>Mariosa D, Beard JD, Umbach DM, Bellocco R, Keller J, Peters TL, Allen KD, Ye W, Sandler DP, Schmidt S, Fang F, Kamel F. Body Mass Index and Amyotrophic Lateral Sclerosis: A Study of US Military Veterans. Am J Epidemiol. 2017;185(5):362&#x2013;71. Epub 2017/02/06. doi: 10.1093/aje/kww140.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/aje/kww140</ArticleId><ArticleId IdType="pmc">PMC5860019</ArticleId><ArticleId IdType="pubmed">28158443</ArticleId></ArticleIdList></Reference><Reference><Citation>Paganoni S, Deng J, Jaffa M, Cudkowicz ME, Wills AM. Body mass index, not dyslipidemia, is an independent predictor of survival in amyotrophic lateral sclerosis. Muscle Nerve. 2011;44(1):20&#x2013;4. Epub 2011/05/25. doi: 10.1002/mus.22114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.22114</ArticleId><ArticleId IdType="pmc">PMC4441750</ArticleId><ArticleId IdType="pubmed">21607987</ArticleId></ArticleIdList></Reference><Reference><Citation>Paganoni S, Hyman T, Shui A, Allred P, Harms M, Liu J, Maragakis N, Schoenfeld D, Yu H, Atassi N, Cudkowicz M, Miller TM. Pre-morbid type 2 diabetes mellitus is not a prognostic factor in amyotrophic lateral sclerosis. Muscle Nerve. 2015;52(3):339&#x2013;43. Epub 2015/04/23. doi: 10.1002/mus.24688.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.24688</ArticleId><ArticleId IdType="pmc">PMC4536144</ArticleId><ArticleId IdType="pubmed">25900666</ArticleId></ArticleIdList></Reference><Reference><Citation>Reich-Slotky R, Andrews J, Cheng B, Buchsbaum R, Levy D, Kaufmann P, Thompson JL. Body mass index (BMI) as predictor of ALSFRS-R score decline in ALS patients. Amyotroph Lateral Scler Frontotemporal Degener. 2013;14(3):212&#x2013;6. Epub 2013/03/05. doi: 10.3109/21678421.2013.770028.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2013.770028</ArticleId><ArticleId IdType="pubmed">23452274</ArticleId></ArticleIdList></Reference><Reference><Citation>Traxinger K, Kelly C, Johnson BA, Lyles RH, Glass JD. Prognosis and epidemiology of amyotrophic lateral sclerosis: Analysis of a clinic population, 1997&#x2013;2011. Neurol Clin Pract. 2013;3(4):313&#x2013;20. Epub 2013/11/07. doi: 10.1212/CPJ.0b013e3182a1b8ab.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/CPJ.0b013e3182a1b8ab</ArticleId><ArticleId IdType="pmc">PMC3787117</ArticleId><ArticleId IdType="pubmed">24195020</ArticleId></ArticleIdList></Reference><Reference><Citation>Gallo V, Wark PA, Jenab M, Pearce N, Brayne C, Vermeulen R, Andersen PM, Hallmans G, Kyrozis A, Vanacore N, Vahdaninia M, Grote V, Kaaks R, Mattiello A, Bueno-de-Mesquita HB, Peeters PH, Travis RC, Petersson J, Hansson O, Arriola L, Jimenez-Martin JM, Tjonneland A, Halkjaer J, Agnoli C, Sacerdote C, Bonet C, Trichopoulou A, Gavrila D, Overvad K, Weiderpass E, Palli D, Quiros JR, Tumino R, Khaw KT, Wareham N, Barricante-Gurrea A, Fedirko V, Ferrari P, Clavel-Chapelon F, Boutron-Ruault MC, Boeing H, Vigl M, Middleton L, Riboli E, Vineis P. Prediagnostic body fat and risk of death from amyotrophic lateral sclerosis: the EPIC cohort. Neurology. 2013;80(9):829&#x2013;38. Epub 2013/02/08. doi: 10.1212/WNL.0b013e3182840689.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e3182840689</ArticleId><ArticleId IdType="pmc">PMC3598455</ArticleId><ArticleId IdType="pubmed">23390184</ArticleId></ArticleIdList></Reference><Reference><Citation>Fitzgerald KC, O&#x2019;Reilly EJ, Falcone GJ, McCullough ML, Park Y, Kolonel LN, Ascherio A. Dietary omega-3 polyunsaturated fatty acid intake and risk for amyotrophic lateral sclerosis. JAMA Neurol. 2014;71(9):1102&#x2013;10. Epub 2014/07/16. doi: 10.1001/jamaneurol.2014.1214.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2014.1214</ArticleId><ArticleId IdType="pmc">PMC4160351</ArticleId><ArticleId IdType="pubmed">25023276</ArticleId></ArticleIdList></Reference><Reference><Citation>Veldink JH, Kalmijn S, Groeneveld GJ, Wunderink W, Koster A, de Vries JH, van der Luyt J, Wokke JH, Van den Berg LH. Intake of polyunsaturated fatty acids and vitamin E reduces the risk of developing amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2007;78(4):367&#x2013;71. Epub 2006/05/02. doi: 10.1136/jnnp.2005.083378.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2005.083378</ArticleId><ArticleId IdType="pmc">PMC2077791</ArticleId><ArticleId IdType="pubmed">16648143</ArticleId></ArticleIdList></Reference><Reference><Citation>Dorst J, Kuhnlein P, Hendrich C, Kassubek J, Sperfeld AD, Ludolph AC. Patients with elevated triglyceride and cholesterol serum levels have a prolonged survival in amyotrophic lateral sclerosis. J Neurol. 2011;258(4):613&#x2013;7. Epub 2010/12/04. doi: 10.1007/s00415-010-5805-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-010-5805-z</ArticleId><ArticleId IdType="pubmed">21128082</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed RM, Highton-Williamson E, Caga J, Thornton N, Ramsey E, Zoing M, Kim WS, Halliday GM, Piguet O, Hodges JR, Farooqi IS, Kiernan MC. Lipid Metabolism and Survival Across the Frontotemporal Dementia-Amyotrophic Lateral Sclerosis Spectrum: Relationships to Eating Behavior and Cognition. J Alzheimers Dis. 2018;61(2):773&#x2013;83. Epub 2017/12/20. doi: 10.3233/JAD-170660.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-170660</ArticleId><ArticleId IdType="pubmed">29254092</ArticleId></ArticleIdList></Reference><Reference><Citation>Dupuis L, Corcia P, Fergani A, De Aguilar JLG, Bonnefont-Rousselot D, Bittar R, Seilhean D, Hauw JJ, Lacomblez L, Loeffler JP, Meininger V. Dyslipidemia is a protective factor in amyotrophic lateral sclerosis. Neurology. 2008;70(13):1004&#x2013;9. doi: DOI 10.1212/01.wnl.0000285080.70324.27.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000285080.70324.27</ArticleId><ArticleId IdType="pubmed">18199832</ArticleId></ArticleIdList></Reference><Reference><Citation>Bandres-Ciga S, Noyce AJ, Hemani G, Nicolas A, Calvo A, Mora G, Consortium I, International ALSGC, Tienari PJ, Stone DJ, Nalls MA, Singleton AB, Chio A, Traynor BJ. Shared polygenic risk and causal inferences in amyotrophic lateral sclerosis. Ann Neurol. 2019. Epub 2019/02/07. doi: 10.1002/ana.25431.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.25431</ArticleId><ArticleId IdType="pmc">PMC6450729</ArticleId><ArticleId IdType="pubmed">30723964</ArticleId></ArticleIdList></Reference><Reference><Citation>Blasco H, Patin F, Molinier S, Vourc&#x2019;h P, Le Tilly O, Bakkouche S, Andres CR, Meininger V, Couratier P, Corcia P. A decrease in blood cholesterol after gastrostomy could impact survival in ALS. Eur J Clin Nutr. 2017;71(9):1133&#x2013;5. doi: 10.1038/ejcn.2017.54.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ejcn.2017.54</ArticleId><ArticleId IdType="pubmed">28422121</ArticleId></ArticleIdList></Reference><Reference><Citation>Fergani A, Oudart H, Gonzalez De Aguilar JL, Fricker B, Rene F, Hocquette JF, Meininger V, Dupuis L, Loeffler JP. Increased peripheral lipid clearance in an animal model of amyotrophic lateral sclerosis. J Lipid Res. 2007;48(7):1571&#x2013;80. Epub 2007/04/18. doi: 10.1194/jlr.M700017-JLR200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1194/jlr.M700017-JLR200</ArticleId><ArticleId IdType="pmc">PMC1974855</ArticleId><ArticleId IdType="pubmed">17438338</ArticleId></ArticleIdList></Reference><Reference><Citation>Stallings NR, Puttaparthi K, Dowling KJ, Luther CM, Burns DK, Davis K, Elliott JL. TDP-43, an ALS linked protein, regulates fat deposition and glucose homeostasis. PLoS One. 2013;8(8):e71793. Epub 2013/08/24. doi: 10.1371/journal.pone.0071793.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0071793</ArticleId><ArticleId IdType="pmc">PMC3742534</ArticleId><ArticleId IdType="pubmed">23967244</ArticleId></ArticleIdList></Reference><Reference><Citation>Lastres-Becker I, Brodesser S, Lutjohann D, Azizov M, Buchmann J, Hintermann E, Sandhoff K, Schurmann A, Nowock J, Auburger G. Insulin receptor and lipid metabolism pathology in ataxin-2 knock-out mice. Hum Mol Genet. 2008;17(10):1465&#x2013;81. Epub 2008/02/06. doi: 10.1093/hmg/ddn035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddn035</ArticleId><ArticleId IdType="pubmed">18250099</ArticleId></ArticleIdList></Reference><Reference><Citation>Coughlan KS, Halang L, Woods I, Prehn JH. A high-fat jelly diet restores bioenergetic balance and extends lifespan in the presence of motor dysfunction and lumbar spinal cord motor neuron loss in TDP-43A315T mutant C57BL6/J mice. Dis Model Mech. 2016;9(9):1029&#x2013;37. Epub 2016/08/05. doi: 10.1242/dmm.024786.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dmm.024786</ArticleId><ArticleId IdType="pmc">PMC5047697</ArticleId><ArticleId IdType="pubmed">27491077</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Z, Sui Y, Gao W, Cai B, Fan D. Effects of diet on adenosine monophosphate-activated protein kinase activity and disease progression in an amyotrophic lateral sclerosis model. J Int Med Res. 2015;43(1):67&#x2013;79. Epub 2014/12/24. doi: 10.1177/0300060514554725.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0300060514554725</ArticleId><ArticleId IdType="pubmed">25534414</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamadeh MJ, Rodriguez MC, Kaczor JJ, Tarnopolsky MA. Caloric restriction transiently improves motor performance but hastens clinical onset of disease in the Cu/Zn-superoxide dismutase mutant G93A mouse. Muscle Nerve. 2005;31(2):214&#x2013;20. Epub 2004/12/31. doi: 10.1002/mus.20255.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.20255</ArticleId><ArticleId IdType="pubmed">15625688</ArticleId></ArticleIdList></Reference><Reference><Citation>Yip PK, Pizzasegola C, Gladman S, Biggio ML, Marino M, Jayasinghe M, Ullah F, Dyall SC, Malaspina A, Bendotti C, Michael-Titus A. The omega-3 fatty acid eicosapentaenoic acid accelerates disease progression in a model of amyotrophic lateral sclerosis. PLoS One. 2013;8(4):e61626. Epub 2013/04/27. doi: 10.1371/journal.pone.0061626.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0061626</ArticleId><ArticleId IdType="pmc">PMC3631166</ArticleId><ArticleId IdType="pubmed">23620776</ArticleId></ArticleIdList></Reference><Reference><Citation>Paoli A, Bianco A, Damiani E, Bosco G. Ketogenic diet in neuromuscular and neurodegenerative diseases. Biomed Res Int. 2014;2014:474296. Epub 2014/08/08. doi: 10.1155/2014/474296.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2014/474296</ArticleId><ArticleId IdType="pmc">PMC4101992</ArticleId><ArticleId IdType="pubmed">25101284</ArticleId></ArticleIdList></Reference><Reference><Citation>Coussee E, De Smet P, Bogaert E, Elens I, Van Damme P, Willems P, Koopman W, Van Den Bosch L, Callewaert G. G37R SOD1 mutant alters mitochondrial complex I activity, Ca(2+) uptake and ATP production. Cell Calcium. 2011;49(4):217&#x2013;25. Epub 2011/03/11. doi: 10.1016/j.ceca.2011.02.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ceca.2011.02.004</ArticleId><ArticleId IdType="pubmed">21388680</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Z, Lange DJ, Voustianiouk A, MacGrogan D, Ho L, Suh J, Humala N, Thiyagarajan M, Wang J, Pasinetti GM. A ketogenic diet as a potential novel therapeutic intervention in amyotrophic lateral sclerosis. BMC Neurosci. 2006;7:29. Epub 2006/04/06. doi: 10.1186/1471-2202-7-29.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2202-7-29</ArticleId><ArticleId IdType="pmc">PMC1488864</ArticleId><ArticleId IdType="pubmed">16584562</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao W, Varghese M, Vempati P, Dzhun A, Cheng A, Wang J, Lange D, Bilski A, Faravelli I, Pasinetti GM. Caprylic triglyceride as a novel therapeutic approach to effectively improve the performance and attenuate the symptoms due to the motor neuron loss in ALS disease. PLoS One. 2012;7(11):e49191. Epub 2012/11/13. doi: 10.1371/journal.pone.0049191.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0049191</ArticleId><ArticleId IdType="pmc">PMC3492315</ArticleId><ArticleId IdType="pubmed">23145119</ArticleId></ArticleIdList></Reference><Reference><Citation>Golko-Perez S, Mandel S, Amit T, Kupershmidt L, Youdim MB, Weinreb O. Additive Neuroprotective Effects of the Multifunctional Iron Chelator M30 with Enriched Diet in a Mouse Model of Amyotrophic Lateral Sclerosis. Neurotox Res. 2016;29(2):208&#x2013;17. Epub 2015/11/20. doi: 10.1007/s12640-015-9574-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12640-015-9574-4</ArticleId><ArticleId IdType="pubmed">26581376</ArticleId></ArticleIdList></Reference><Reference><Citation>Palamiuc L, Schlagowski A, Ngo ST, Vernay A, Dirrig-Grosch S, Henriques A, Boutillier AL, Zoll J, Echaniz-Laguna A, Loeffler JP, Rene F. A metabolic switch toward lipid use in glycolytic muscle is an early pathologic event in a mouse model of amyotrophic lateral sclerosis. EMBO Mol Med. 2015;7(5):526&#x2013;46. Epub 2015/03/31. doi: 10.15252/emmm.201404433.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/emmm.201404433</ArticleId><ArticleId IdType="pmc">PMC4492815</ArticleId><ArticleId IdType="pubmed">25820275</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim SM, Kim H, Kim JE, Park KS, Sung JJ, Kim SH, Lee KW. Amyotrophic lateral sclerosis is associated with hypolipidemia at the presymptomatic stage in mice. PLoS One. 2011;6(3):e17985. Epub 2011/04/06. doi: 10.1371/journal.pone.0017985.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0017985</ArticleId><ArticleId IdType="pmc">PMC3064597</ArticleId><ArticleId IdType="pubmed">21464953</ArticleId></ArticleIdList></Reference><Reference><Citation>Wills AM, Hubbard J, Macklin EA, Glass J, Tandan R, Simpson EP, Brooks B, Gelinas D, Mitsumoto H, Mozaffar T, Hanes GP, Ladha SS, Heiman-Patterson T, Katz J, Lou JS, Mahoney K, Grasso D, Lawson R, Yu H, Cudkowicz M, Network MDACR. Hypercaloric enteral nutrition in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled phase 2 trial. Lancet. 2014;383(9934):2065&#x2013;72. Epub 2014/03/04. doi: 10.1016/S0140-6736(14)60222-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(14)60222-1</ArticleId><ArticleId IdType="pmc">PMC4176708</ArticleId><ArticleId IdType="pubmed">24582471</ArticleId></ArticleIdList></Reference><Reference><Citation>Tauffenberger A, Vaccaro A, Aulas A, Vande Velde C, Parker JA. Glucose delays age-dependent proteotoxicity. Aging Cell. 2012;11(5):856&#x2013;66. Epub 2012/06/28. doi: 10.1111/j.1474-9726.2012.00855.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1474-9726.2012.00855.x</ArticleId><ArticleId IdType="pmc">PMC3470697</ArticleId><ArticleId IdType="pubmed">22734670</ArticleId></ArticleIdList></Reference><Reference><Citation>Aaron C, Beaudry G, Parker JA, Therrien M. Maple Syrup Decreases TDP-43 Proteotoxicity in a Caenorhabditis elegans Model of Amyotrophic Lateral Sclerosis (ALS). J Agric Food Chem. 2016;64(17):3338&#x2013;44. Epub 2016/04/14. doi: 10.1021/acs.jafc.5b05432.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jafc.5b05432</ArticleId><ArticleId IdType="pubmed">27071850</ArticleId></ArticleIdList></Reference><Reference><Citation>Nieves JW, Gennings C, Factor-Litvak P, Hupf J, Singleton J, Sharf V, Oskarsson B, Fernandes Filho JA, Sorenson EJ, D&#x2019;Amico E, Goetz R, Mitsumoto H, Amyotrophic Lateral Sclerosis Multicenter Cohort Study of Oxidative Stress Study G. Association Between Dietary Intake and Function in Amyotrophic Lateral Sclerosis. JAMA Neurol. 2016;73(12):1425&#x2013;32. Epub 2016/10/25. doi: 10.1001/jamaneurol.2016.3401.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2016.3401</ArticleId><ArticleId IdType="pmc">PMC5370581</ArticleId><ArticleId IdType="pubmed">27775751</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin Y, Oh K, Oh SI, Baek H, Kim SH, Park Y. Dietary intake of fruits and beta-carotene is negatively associated with amyotrophic lateral sclerosis risk in Koreans: a case-control study. Nutr Neurosci. 2014;17(3):104&#x2013;8. Epub 2013/05/29. doi: 10.1179/1476830513Y.0000000071.</Citation><ArticleIdList><ArticleId IdType="doi">10.1179/1476830513Y.0000000071</ArticleId><ArticleId IdType="pubmed">23710627</ArticleId></ArticleIdList></Reference><Reference><Citation>Stefani M, Rigacci S. Protein folding and aggregation into amyloid: the interference by natural phenolic compounds. Int J Mol Sci. 2013;14(6):12411&#x2013;57. Epub 2013/06/15. doi: 10.3390/ijms140612411.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms140612411</ArticleId><ArticleId IdType="pmc">PMC3709793</ArticleId><ArticleId IdType="pubmed">23765219</ArticleId></ArticleIdList></Reference><Reference><Citation>Angeloni C, Malaguti M, Barbalace MC, Hrelia S. Bioactivity of Olive Oil Phenols in Neuroprotection. Int J Mol Sci. 2017;18(11). Epub 2017/10/27. doi: 10.3390/ijms18112230.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms18112230</ArticleId><ArticleId IdType="pmc">PMC5713200</ArticleId><ArticleId IdType="pubmed">29068387</ArticleId></ArticleIdList></Reference><Reference><Citation>Olivan S, Martinez-Beamonte R, Calvo AC, Surra JC, Manzano R, Arnal C, Osta R, Osada J. Extra virgin olive oil intake delays the development of amyotrophic lateral sclerosis associated with reduced reticulum stress and autophagy in muscle of SOD1G93A mice. J Nutr Biochem. 2014;25(8):885&#x2013;92. Epub 2014/06/12. doi: 10.1016/j.jnutbio.2014.04.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jnutbio.2014.04.005</ArticleId><ArticleId IdType="pubmed">24917047</ArticleId></ArticleIdList></Reference><Reference><Citation>De Paola M, Sestito SE, Mariani A, Memo C, Fanelli R, Freschi M, Bendotti C, Calabrese V, Peri F. Synthetic and natural small molecule TLR4 antagonists inhibit motoneuron death in cultures from ALS mouse model. Pharmacol Res. 2016;103:180&#x2013;7. Epub 2015/12/08. doi: 10.1016/j.phrs.2015.11.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phrs.2015.11.020</ArticleId><ArticleId IdType="pubmed">26640075</ArticleId></ArticleIdList></Reference><Reference><Citation>Winter AN, Ross EK, Wilkins HM, Stankiewicz TR, Wallace T, Miller K, Linseman DA. An anthocyanin-enriched extract from strawberries delays disease onset and extends survival in the hSOD1(G93A) mouse model of amyotrophic lateral sclerosis. Nutr Neurosci. 2018;21(6):414&#x2013;26. Epub 2017/03/10. doi: 10.1080/1028415X.2017.1297023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/1028415X.2017.1297023</ArticleId><ArticleId IdType="pubmed">28276271</ArticleId></ArticleIdList></Reference><Reference><Citation>Bravo L Polyphenols: chemistry, dietary sources, metabolism, and nutritional significance. Nutr Rev. 1998;56(11):317&#x2013;33. Epub 1998/12/05. doi: 10.1111/j.1753-4887.1998.tb01670.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1753-4887.1998.tb01670.x</ArticleId><ArticleId IdType="pubmed">9838798</ArticleId></ArticleIdList></Reference><Reference><Citation>Ari C, Poff AM, Held HE, Landon CS, Goldhagen CR, Mavromates N, D&#x2019;Agostino DP. Metabolic therapy with Deanna Protocol supplementation delays disease progression and extends survival in amyotrophic lateral sclerosis (ALS) mouse model. PLoS One. 2014;9(7):e103526. Epub 2014/07/26. doi: 10.1371/journal.pone.0103526.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0103526</ArticleId><ArticleId IdType="pmc">PMC4111621</ArticleId><ArticleId IdType="pubmed">25061944</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner MR, Goldacre R, Ramagopalan S, Talbot K, Goldacre MJ. Autoimmune disease preceding amyotrophic lateral sclerosis: an epidemiologic study. Neurology. 2013;81(14):1222&#x2013;5. Epub 2013/08/16. doi: 10.1212/WNL.0b013e3182a6cc13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e3182a6cc13</ArticleId><ArticleId IdType="pmc">PMC3795611</ArticleId><ArticleId IdType="pubmed">23946298</ArticleId></ArticleIdList></Reference><Reference><Citation>Gadoth A, Nefussy B, Bleiberg M, Klein T, Artman I, Drory VE. Transglutaminase 6 Antibodies in the Serum of Patients With Amyotrophic Lateral Sclerosis. JAMA Neurol. 2015;72(6):676&#x2013;81. Epub 2015/04/14. doi: 10.1001/jamaneurol.2015.48.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2015.48</ArticleId><ArticleId IdType="pubmed">25867286</ArticleId></ArticleIdList></Reference><Reference><Citation>Visser AE, Pazoki R, Pulit SL, van Rheenen W, Raaphorst J, van der Kooi AJ, Ricano-Ponce I, Wijmenga C, Otten HG, Veldink JH, van den Berg LH. No association between gluten sensitivity and amyotrophic lateral sclerosis. J Neurol. 2017;264(4):694&#x2013;700. Epub 2017/02/09. doi: 10.1007/s00415-017-8400-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-017-8400-8</ArticleId><ArticleId IdType="pmc">PMC5374172</ArticleId><ArticleId IdType="pubmed">28168522</ArticleId></ArticleIdList></Reference><Reference><Citation>Ludvigsson JF, Mariosa D, Lebwohl B, Fang F. No association between biopsy-verified celiac disease and subsequent amyotrophic lateral sclerosis--a population-based cohort study. Eur J Neurol. 2014;21(7):976&#x2013;82. Epub 2014/04/09. doi: 10.1111/ene.12419.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.12419</ArticleId><ArticleId IdType="pmc">PMC4057356</ArticleId><ArticleId IdType="pubmed">24708265</ArticleId></ArticleIdList></Reference><Reference><Citation>Ham H, Lee BI, Oh HJ, Park SH, Kim JS, Park JM, Cho YS, Choi MG. A case of celiac disease with neurologic manifestations misdiagnosed as amyotrophic lateral sclerosis. Intest Res. 2017;15(4):540&#x2013;2. Epub 2017/11/17. doi: 10.5217/ir.2017.15.4.540.</Citation><ArticleIdList><ArticleId IdType="doi">10.5217/ir.2017.15.4.540</ArticleId><ArticleId IdType="pmc">PMC5683987</ArticleId><ArticleId IdType="pubmed">29142524</ArticleId></ArticleIdList></Reference><Reference><Citation>Karam CY, Paganoni S, Joyce N, Carter GT, Bedlack R. Palliative Care Issues in Amyotrophic Lateral Sclerosis: An Evidenced-Based Review. Am J Hosp Palliat Care. 2016;33(1):84&#x2013;92. Epub 2014/09/10. doi: 10.1177/1049909114548719.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1049909114548719</ArticleId><ArticleId IdType="pmc">PMC4439378</ArticleId><ArticleId IdType="pubmed">25202033</ArticleId></ArticleIdList></Reference><Reference><Citation>Paganoni S, Macklin EA, Karam C, Yu H, Gonterman F, Fetterman KA, Cudkowicz M, Berry J, Wills AM. Vitamin D levels are associated with gross motor function in amyotrophic lateral sclerosis. Muscle Nerve. 2017;56(4):726&#x2013;31. Epub 2017/01/04. doi: 10.1002/mus.25555.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.25555</ArticleId><ArticleId IdType="pubmed">28044349</ArticleId></ArticleIdList></Reference><Reference><Citation>Gianforcaro A, Hamadeh MJ. Vitamin D as a Potential Therapy in Amyotrophic Lateral Sclerosis. Cns Neurosci Ther. 2014;20(2):101&#x2013;11. doi: 10.1111/cns.12204.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cns.12204</ArticleId><ArticleId IdType="pmc">PMC6493003</ArticleId><ArticleId IdType="pubmed">24428861</ArticleId></ArticleIdList></Reference><Reference><Citation>Camu W, Tremblier B, Plassot C, Alphandery S, Salsac C, Pageot N, Juntas-Morales R, Scamps F, Daures JP, Raoul C. Vitamin D confers protection to motoneurons and is a prognostic factor of amyotrophic lateral sclerosis. Neurobiol Aging. 2014;35(5):1198&#x2013;205. doi: 10.1016/j.neurobiolaging.2013.11.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2013.11.005</ArticleId><ArticleId IdType="pubmed">24378089</ArticleId></ArticleIdList></Reference><Reference><Citation>Moghimi E, Solomon JA, Gianforcaro A, Hamadeh MJ. Dietary Vitamin D3 Restriction Exacerbates Disease Pathophysiology in the Spinal Cord of the G93A Mouse Model of Amyotrophic Lateral Sclerosis. PLoS One. 2015;10(5):e0126355. Epub 2015/05/29. doi: 10.1371/journal.pone.0126355.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0126355</ArticleId><ArticleId IdType="pmc">PMC4447353</ArticleId><ArticleId IdType="pubmed">26020962</ArticleId></ArticleIdList></Reference><Reference><Citation>Libonati L, Onesti E, Gori MC, Ceccanti M, Cambieri C, Fabbri A, Frasca V, Inghilleri M. Vitamin D in amyotrophic lateral sclerosis. Funct Neurol. 2017;32(1):35&#x2013;40. Epub 2017/04/06.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5505528</ArticleId><ArticleId IdType="pubmed">28380322</ArticleId></ArticleIdList></Reference><Reference><Citation>Blasco H, Madji Hounoum B, Dufour-Rainfray D, Patin F, Maillot F, Beltran S, Gordon PH, Andres CR, Corcia P. Vitamin D is Not a Protective Factor in ALS. Cns Neurosci Ther. 2015;21(8):651&#x2013;6. Epub 2015/06/23. doi: 10.1111/cns.12423.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cns.12423</ArticleId><ArticleId IdType="pmc">PMC6495158</ArticleId><ArticleId IdType="pubmed">26096806</ArticleId></ArticleIdList></Reference><Reference><Citation>Ascherio A, Weisskopf MG, O&#x2019;Reilly EJ, Jacobs EJ, McCullough ML, Calle EE, Cudkowicz M, Thun MJ. Vitamin E intake and risk of amyotrophic lateral sclerosis. Ann Neurol. 2005;57(1):104&#x2013;10. Epub 2004/11/06. doi: 10.1002/ana.20316.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.20316</ArticleId><ArticleId IdType="pubmed">15529299</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H, O&#x2019;Reilly EJ, Weisskopf MG, Logroscino G, McCullough ML, Schatzkin A, Kolonel LN, Ascherio A. Vitamin E intake and risk of amyotrophic lateral sclerosis: a pooled analysis of data from 5 prospective cohort studies. Am J Epidemiol. 2011;173(6):595&#x2013;602. Epub 2011/02/22. doi: 10.1093/aje/kwq416.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/aje/kwq416</ArticleId><ArticleId IdType="pmc">PMC3105261</ArticleId><ArticleId IdType="pubmed">21335424</ArticleId></ArticleIdList></Reference><Reference><Citation>Cox PA, Davis DA, Mash DC, Metcalf JS, Banack SA. Dietary exposure to an environmental toxin triggers neurofibrillary tangles and amyloid deposits in the brain. Proc Biol Sci. 2016;283(1823). Epub 2016/01/23. doi: 10.1098/rspb.2015.2397.</Citation><ArticleIdList><ArticleId IdType="doi">10.1098/rspb.2015.2397</ArticleId><ArticleId IdType="pmc">PMC4795023</ArticleId><ArticleId IdType="pubmed">26791617</ArticleId></ArticleIdList></Reference><Reference><Citation>Metcalf JS, Dunlop RA, Powell JT, Banack SA, Cox PA. L-Serine: a Naturally-Occurring Amino Acid with Therapeutic Potential. Neurotox Res. 2018;33(1):213&#x2013;21. Epub 2017/09/21. doi: 10.1007/s12640-017-9814-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12640-017-9814-x</ArticleId><ArticleId IdType="pubmed">28929385</ArticleId></ArticleIdList></Reference><Reference><Citation>Bradley WG, Miller RX, Levine TD, Stommel EW, Cox PA. Studies of Environmental Risk Factors in Amyotrophic Lateral Sclerosis (ALS) and a Phase I Clinical Trial of L-Serine. Neurotox Res. 2018;33(1):192&#x2013;8. Epub 2017/05/21. doi: 10.1007/s12640-017-9741-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12640-017-9741-x</ArticleId><ArticleId IdType="pubmed">28527102</ArticleId></ArticleIdList></Reference><Reference><Citation>Levine TD, Miller RG, Bradley WG, Moore DH, Saperstein DS, Flynn LE, Katz JS, Forshew DA, Metcalf JS, Banack SA, Cox PA. Phase I clinical trial of safety of L-serine for ALS patients. Amyotroph Lateral Scler Frontotemporal Degener. 2017;18(1&#x2013;2):107&#x2013;11. Epub 2016/09/04. doi: 10.1080/21678421.2016.1221971.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2016.1221971</ArticleId><ArticleId IdType="pubmed">27589995</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindauer E, Dupuis L, Muller HP, Neumann H, Ludolph AC, Kassubek J. Adipose Tissue Distribution Predicts Survival in Amyotrophic Lateral Sclerosis. PLoS One. 2013;8(6):e67783. Epub 2013/07/05. doi: 10.1371/journal.pone.0067783.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0067783</ArticleId><ArticleId IdType="pmc">PMC3694869</ArticleId><ArticleId IdType="pubmed">23826340</ArticleId></ArticleIdList></Reference><Reference><Citation>McCombe PA, Henderson RD. Effects of gender in amyotrophic lateral sclerosis. Gend Med. 2010;7(6):557&#x2013;70. Epub 2011/01/05. doi: 10.1016/j.genm.2010.11.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.genm.2010.11.010</ArticleId><ArticleId IdType="pubmed">21195356</ArticleId></ArticleIdList></Reference><Reference><Citation>Talbott EO, Malek AM, Lacomis D. The epidemiology of amyotrophic lateral sclerosis. Handb Clin Neurol. 2016;138:225&#x2013;38. Epub 2016/09/18. doi: 10.1016/B978-0-12-802973-2.00013-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/B978-0-12-802973-2.00013-6</ArticleId><ArticleId IdType="pubmed">27637961</ArticleId></ArticleIdList></Reference><Reference><Citation>Couratier P, Corcia P, Lautrette G, Nicol M, Preux PM, Marin B. Epidemiology of amyotrophic lateral sclerosis: A review of literature. Rev Neurol (Paris). 2016;172(1):37&#x2013;45. Epub 2016/01/05. doi: 10.1016/j.neurol.2015.11.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurol.2015.11.002</ArticleId><ArticleId IdType="pubmed">26727307</ArticleId></ArticleIdList></Reference><Reference><Citation>Zarei S, Carr K, Reiley L, Diaz K, Guerra O, Altamirano PF, Pagani W, Lodin D, Orozco G, Chinea A. A comprehensive review of amyotrophic lateral sclerosis. Surg Neurol Int. 2015;6:171. Epub 2015/12/03. doi: 10.4103/2152-7806.169561.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/2152-7806.169561</ArticleId><ArticleId IdType="pmc">PMC4653353</ArticleId><ArticleId IdType="pubmed">26629397</ArticleId></ArticleIdList></Reference><Reference><Citation>Manjaly ZR, Scott KM, Abhinav K, Wijesekera L, Ganesalingam J, Goldstein LH, Janssen A, Dougherty A, Willey E, Stanton BR, Turner MR, Ampong MA, Sakel M, Orrell RW, Howard R, Shaw CE, Leigh PN, Al-Chalabi A. The sex ratio in amyotrophic lateral sclerosis: A population based study. Amyotroph Lateral Sc. 2010;11(5):439&#x2013;42. doi: 10.3109/17482961003610853.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482961003610853</ArticleId><ArticleId IdType="pmc">PMC6485484</ArticleId><ArticleId IdType="pubmed">20225930</ArticleId></ArticleIdList></Reference><Reference><Citation>Cudkowicz ME, Pastusza KA, Sapp PC, Mathews RK, Leahy J, Pasinelli P, Francis JW, Jiang D, Andersen JK, Brown RH Jr. Survival in transgenic ALS mice does not vary with CNS glutathione peroxidase activity. Neurology. 2002;59(5):729&#x2013;34. Epub 2002/09/11.</Citation><ArticleIdList><ArticleId IdType="pubmed">12221165</ArticleId></ArticleIdList></Reference><Reference><Citation>Snow RJ, Turnbull J, da Silva S, Jiang F, Tarnopolsky MA. Creatine supplementation and riluzole treatment provide similar beneficial effects in copper, zinc superoxide dismutase (G93A) transgenic mice. Neuroscience. 2003;119(3):661&#x2013;7. Epub 2003/06/18.</Citation><ArticleIdList><ArticleId IdType="pubmed">12809687</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayworth CR, Gonzalez-Lima F. Pre-symptomatic detection of chronic motor deficits and genotype prediction in congenic B6.SOD1(G93A) ALS mouse model. Neuroscience. 2009;164(3):975&#x2013;85. Epub 2009/08/25. doi: 10.1016/j.neuroscience.2009.08.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2009.08.031</ArticleId><ArticleId IdType="pmc">PMC2783710</ArticleId><ArticleId IdType="pubmed">19699279</ArticleId></ArticleIdList></Reference><Reference><Citation>Shan X, Chiang PM, Price DL, Wong PC. Altered distributions of Gemini of coiled bodies and mitochondria in motor neurons of TDP-43 transgenic mice. Proceedings of the National Academy of Sciences of the United States of America. 2010;107(37):16325&#x2013;30. doi: 10.1073/pnas.1003459107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1003459107</ArticleId><ArticleId IdType="pmc">PMC2941282</ArticleId><ArticleId IdType="pubmed">20736350</ArticleId></ArticleIdList></Reference><Reference><Citation>Vrtacnik P, Ostanek B, Mencej-Bedrac S, Marc J. The many faces of estrogen signaling. Biochem Med (Zagreb). 2014;24(3):329&#x2013;42. Epub 2014/10/30. doi: 10.11613/BM.2014.035.</Citation><ArticleIdList><ArticleId IdType="doi">10.11613/BM.2014.035</ArticleId><ArticleId IdType="pmc">PMC4210253</ArticleId><ArticleId IdType="pubmed">25351351</ArticleId></ArticleIdList></Reference><Reference><Citation>de Jong S, Huisman M, Sutedja N, van der Kooi A, de Visser M, Schelhaas J, van der Schouw Y, Veldink J, van den Berg L. Endogenous female reproductive hormones and the risk of amyotrophic lateral sclerosis. J Neurol. 2013;260(2):507&#x2013;12. doi: 10.1007/s00415-012-6665-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-012-6665-5</ArticleId><ArticleId IdType="pubmed">22972621</ArticleId></ArticleIdList></Reference><Reference><Citation>Monachelli GG, Meyer M, Rodriguez GE, Garay LI, Sica REP, De Nicola AF, Deniselle MCG. Endogenous progesterone is associated to amyotrophic lateral sclerosis prognostic factors. Acta Neurol Scand. 2011;123(1):60&#x2013;7. doi: 10.1111/j.1600-0404.2010.01385.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-0404.2010.01385.x</ArticleId><ArticleId IdType="pubmed">20545634</ArticleId></ArticleIdList></Reference><Reference><Citation>Chandra A, Martinez GM, Mosher WD, Abma JC, Jones J. Fertility, family planning, and reproductive health of U.S. women: data from the 2002 National Survey of Family Growth. Vital Health Stat 23. 2005(25):1&#x2013;160. Epub 2006/03/15.</Citation><ArticleIdList><ArticleId IdType="pubmed">16532609</ArticleId></ArticleIdList></Reference><Reference><Citation>Rooney JPK, Visser AE, D&#x2019;Ovidio F, Vermeulen R, Beghi E, Chio A, Veldink JH, Logroscino G, van den Berg LH, Hardiman O, Consortium E-M. A case-control study of hormonal exposures as etiologic factors for ALS in women Euro-MOTOR. Neurology. 2017;89(12):1283&#x2013;90. doi: 10.1212/Wnl.0000000000004390.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/Wnl.0000000000004390</ArticleId><ArticleId IdType="pubmed">28835399</ArticleId></ArticleIdList></Reference><Reference><Citation>Popat RA, Van Den Eeden SK, Tanner CM, Bernstein AL, Bloch DA, Leimpeter A, McGuire V, Nelson LM. Effect of reproductive factors and postmenopausal hormone use on the risk of amyotrophic lateral sclerosis. Neuroepidemiology. 2006;27(3):117&#x2013;21. doi: 10.1159/000095550.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000095550</ArticleId><ArticleId IdType="pubmed">16946622</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi CI, Lee YD, Gwag BJ, Cho SI, Kim SS, Suh-Kim H. Effects of estrogen on lifespan and motor functions in female hSOD1 G93A transgenic mice. J Neurol Sci. 2008;268(1&#x2013;2):40&#x2013;7. doi: 10.1016/j.jns.2007.10.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2007.10.024</ArticleId><ArticleId IdType="pubmed">18054961</ArticleId></ArticleIdList></Reference><Reference><Citation>Groeneveld GJ, Van Muiswinkel FL, Sturkenboom JM, Wokke JH, Bar PR, Van den Berg LH. Ovariectomy and 17beta-estradiol modulate disease progression of a mouse model of ALS. Brain Res. 2004;1021(1):128&#x2013;31. doi: 10.1016/j.brainres.2004.06.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2004.06.024</ArticleId><ArticleId IdType="pubmed">15328040</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan L, Liu Y, Sun C, Zheng Q, Hao P, Zhai J, Liu Y. Effects of Ovariectomy in an hSOD1-G93A Transgenic Mouse Model of Amyotrophic Lateral Sclerosis (ALS). Med Sci Monit. 2018;24:678&#x2013;86. Epub 2018/02/03.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5806477</ArticleId><ArticleId IdType="pubmed">29394243</ArticleId></ArticleIdList></Reference><Reference><Citation>Heitzer M, Kaiser S, Kanagaratnam M, Zendedel A, Hartmann P, Beyer C, Johann S. Administration of 17beta-Estradiol Improves Motoneuron Survival and Down-regulates Inflammasome Activation in Male SOD1(G93A) ALS Mice. Mol Neurobiol. 2017;54(10):8429&#x2013;43. doi: 10.1007/s12035-016-0322-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-016-0322-4</ArticleId><ArticleId IdType="pubmed">27957680</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim J, Kim TY, Cho KS, Kim HN, Koh JY. Autophagy activation and neuroprotection by progesterone in the G93A-SOD1 transgenic mouse model of amyotrophic lateral sclerosis. Neurobiol Dis. 2013;59:80&#x2013;5. Epub 2013/07/31. doi: 10.1016/j.nbd.2013.07.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2013.07.011</ArticleId><ArticleId IdType="pubmed">23891729</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzalez Deniselle MC, Liere P, Pianos A, Meyer M, Aprahamian F, Cambourg A, Di Giorgio NP, Schumacher M, De Nicola AF, Guennoun R. Steroid Profiling in Male Wobbler Mouse, a Model of Amyotrophic Lateral Sclerosis. Endocrinology. 2016;157(11):4446&#x2013;60. Epub 2016/11/02. doi: 10.1210/en.2016-1244.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/en.2016-1244</ArticleId><ArticleId IdType="pubmed">27571131</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzalez Deniselle MC, Carreras MC, Garay L, Gargiulo-Monachelli G, Meyer M, Poderoso JJ, De Nicola AF. Progesterone prevents mitochondrial dysfunction in the spinal cord of wobbler mice. J Neurochem. 2012;122(1):185&#x2013;95. Epub 2012/04/11. doi: 10.1111/j.1471-4159.2012.07753.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2012.07753.x</ArticleId><ArticleId IdType="pubmed">22486171</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzalez Deniselle MC, Lopez-Costa JJ, Saavedra JP, Pietranera L, Gonzalez SL, Garay L, Guennoun R, Schumacher M, De Nicola AF. Progesterone neuroprotection in the Wobbler mouse, a genetic model of spinal cord motor neuron disease. Neurobiol Dis. 2002;11(3):457&#x2013;68. Epub 2003/02/15.</Citation><ArticleIdList><ArticleId IdType="pubmed">12586554</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzalez Deniselle MC, Garay L, Gonzalez S, Guennoun R, Schumacher M, De Nicola AF. Progesterone restores retrograde labeling of cervical motoneurons in Wobbler mouse motoneuron disease. Exp Neurol. 2005;195(2):518&#x2013;23. Epub 2005/08/13. doi: 10.1016/j.expneurol.2005.06.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2005.06.015</ArticleId><ArticleId IdType="pubmed">16095593</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzalez Deniselle MC, Garay L, Lopez-Costa JJ, Gonzalez S, Mougel A, Guennoun R, Schumacher M, De Nicola AF. Progesterone treatment reduces NADPH-diaphorase/nitric oxide synthase in Wobbler mouse motoneuron disease. Brain Res. 2004;1014(1&#x2013;2):71&#x2013;9. Epub 2004/06/24. doi: 10.1016/j.brainres.2004.04.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2004.04.004</ArticleId><ArticleId IdType="pubmed">15212993</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyer M, Gonzalez Deniselle MC, Garay LI, Monachelli GG, Lima A, Roig P, Guennoun R, Schumacher M, De Nicola AF. Stage dependent effects of progesterone on motoneurons and glial cells of wobbler mouse spinal cord degeneration. Cell Mol Neurobiol. 2010;30(1):123&#x2013;35. Epub 2009/08/21. doi: 10.1007/s10571-009-9437-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10571-009-9437-8</ArticleId><ArticleId IdType="pubmed">19693665</ArticleId></ArticleIdList></Reference><Reference><Citation>Moser JM, Bigini P, Schmitt-John T. The wobbler mouse, an ALS animal model. Mol Genet Genomics. 2013;288(5&#x2013;6):207&#x2013;29. Epub 2013/03/30. doi: 10.1007/s00438-013-0741-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00438-013-0741-0</ArticleId><ArticleId IdType="pmc">PMC3664746</ArticleId><ArticleId IdType="pubmed">23539154</ArticleId></ArticleIdList></Reference><Reference><Citation>Gargiulo-Monachelli GM, Sivori M, Meyer M, Sica RE, De Nicola AF, Gonzalez-Deniselle MC. Circulating gonadal and adrenal steroids in amyotrophic lateral sclerosis: possible markers of susceptibility and outcome. Horm Metab Res. 2014;46(6):433&#x2013;9. Epub 2014/05/09. doi: 10.1055/s-0034-1371891.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0034-1371891</ArticleId><ArticleId IdType="pubmed">24806746</ArticleId></ArticleIdList></Reference><Reference><Citation>Militello A, Vitello G, Lunetta C, Toscano A, Maiorana G, Piccoli T, La Bella V. The serum level of free testosterone is reduced in amyotrophic lateral sclerosis. Journal of the Neurological Sciences. 2002;195(1):67&#x2013;70. doi: Pii S0022&#x2013;510x(01)00688&#x2013;8 Doi 10.1016/S0022-510x(01)00688-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-510x(01)00688-8</ArticleId><ArticleId IdType="pubmed">11867076</ArticleId></ArticleIdList></Reference><Reference><Citation>Vivekananda U, Manjalay ZR, Ganesalingam J, Simms J, Shaw CE, Leigh PN, Turner MR, Al-Chalabi A. Low index-to-ring finger length ratio in sporadic ALS supports prenatally defined motor neuronal vulnerability. J Neurol Neurosurg Psychiatry. 2011;82(6):635&#x2013;7. Epub 2011/05/10. doi: 10.1136/jnnp.2010.237412.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2010.237412</ArticleId><ArticleId IdType="pubmed">21551173</ArticleId></ArticleIdList></Reference><Reference><Citation>Parkin Kullmann JA, Pamphlett R. Does the index-to-ring finger length ratio (2D:4D) differ in amyotrophic lateral sclerosis (ALS)? Results from an international online case-control study. BMJ Open. 2017;7(8):e016924. Epub 2017/08/09. doi: 10.1136/bmjopen-2017-016924.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2017-016924</ArticleId><ArticleId IdType="pmc">PMC5726056</ArticleId><ArticleId IdType="pubmed">28784596</ArticleId></ArticleIdList></Reference><Reference><Citation>de Almeida JP, Silvestre R, Pinto AC, de Carvalho M. Exercise and amyotrophic lateral sclerosis. Neurol Sci. 2012;33(1):9&#x2013;15. Epub 2012/01/10. doi: 10.1007/s10072-011-0921-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-011-0921-9</ArticleId><ArticleId IdType="pubmed">22228269</ArticleId></ArticleIdList></Reference><Reference><Citation>Veldink JH, Bar PR, Joosten EA, Otten M, Wokke JH, van den Berg LH. Sexual differences in onset of disease and response to exercise in a transgenic model of ALS. Neuromuscul Disord. 2003;13(9):737&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pubmed">14561497</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahoney DJ, Rodriguez C, Devries M, Yasuda N, Tarnopolsky MA. Effects of high-intensity endurance exercise training in the G93A mouse model of amyotrophic lateral sclerosis. Muscle Nerve. 2004;29(5):656&#x2013;62. Epub 2004/04/30. doi: 10.1002/mus.20004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.20004</ArticleId><ArticleId IdType="pubmed">15116368</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim MA, Bence KK, Sandesara I, Andreux P, Auwerx J, Ishibashi J, Seale P, Kalb RG. Genetically altering organismal metabolism by leptin-deficiency benefits a mouse model of amyotrophic lateral sclerosis. Hum Mol Genet. 2014;23(18):4995&#x2013;5008. Epub 2014/05/17. doi: 10.1093/hmg/ddu214.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddu214</ArticleId><ArticleId IdType="pmc">PMC4140473</ArticleId><ArticleId IdType="pubmed">24833719</ArticleId></ArticleIdList></Reference><Reference><Citation>Pape JA, Newey CR, Burrell HR, Workman A, Perry K, Bikman BT, Bridgewater LC, Grose JH. Per-Arnt-Sim Kinase (PASK) Deficiency Increases Cellular Respiration on a Standard Diet and Decreases Liver Triglyceride Accumulation on a Western High-Fat High-Sugar Diet. Nutrients. 2018;10(12). Epub 2018/12/19. doi: 10.3390/nu10121990.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu10121990</ArticleId><ArticleId IdType="pmc">PMC6316003</ArticleId><ArticleId IdType="pubmed">30558306</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>